A Post-market Registry to Assess Safety and Performance of RefluxStop™ in the Treatment of GERD in General Hospital Practice

NANot yet recruitingINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

August 1, 2029

Study Completion Date

August 1, 2035

Conditions

Gastroesophageal Reflux Disease

Interventions

DEVICE

RefluxStop™ implantation

Standard surgical technique for implantation RefluxStop™, as described in the Instructions for Use

Trial Locations (5)

Klinikum Friedrichshafen GmbH, Friedrichshafen

H. Universitario Getafe, Getafe

H. La Mancha Centro, Alcázar de San Juan

H. Infanta Sofía, Madrid

H. Ramón y Cajal, Madrid

All Listed Sponsors

lead

Implantica CE Reflux Ltd.

INDUSTRY